Caption Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,290
| Closed | -$116K | – | 1193 |
|
|
2024
Q4 | $116K | Buy |
+38,290
| New | +$116K | ﹤0.01% | 433 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 924 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 888 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 973 |
|
|
2023
Q4 | – | Sell |
-35,400
| Closed | -$406K | – | 948 |
|
|
2023
Q3 | $406K | Sell |
35,400
-4,800
| -12% | -$55.1K | 0.01% | 237 |
|
|
2023
Q2 | $1.02M | Buy |
+40,200
| New | +$1.02M | 0.02% | 122 |
|
|
2023
Q1 | – | Sell |
-147,500
| Closed | -$2.72M | – | 903 |
|
|
2022
Q4 | $2.72M | Buy |
+147,500
| New | +$2.72M | 0.04% | 52 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 945 |
|